Lifeclean Q3’22: Weak sales development - Redeye

Redeye saw sales substantially lower than our expectations for the quarter. The gross margin and Opex was in line with expectations. The slower sales development and increased risk-free rate in our model will lower our Base case and fair value range.

Länk till analysen i sin helhet: https://www.redeye.se/research/861150/lifeclean-q322-weak-sales-development?utm_source=finwire&utm_medium=RSS